1. Home
  2. CLDI vs OFAL Comparison

CLDI vs OFAL Comparison

Compare CLDI & OFAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

N/A

Current Price

$0.65

Market Cap

1.7M

Sector

Health Care

ML Signal

N/A

Logo OFA Group Ordinary Shares

OFAL

OFA Group Ordinary Shares

HOLD

Current Price

$0.31

Market Cap

1.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLDI
OFAL
Founded
2014
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Military/Government/Technical
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.7M
1.7M
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
CLDI
OFAL
Price
$0.65
$0.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
40.3K
★ 13.6M
Earning Date
11-12-2026
07-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
$45,000.00
★ $716,885.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 254.88
52 Week Low
$0.09
$0.01
52 Week High
$3.38
$0.75

Technical Indicators

Market Signals
Indicator
CLDI
OFAL
Relative Strength Index (RSI) 26.99 59.19
Support Level $0.62 $0.04
Resistance Level $1.29 $0.38
Average True Range (ATR) 0.07 0.03
MACD -0.01 -0.01
Stochastic Oscillator 14.15 7.20

Price Performance

Historical Comparison
CLDI
OFAL

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. Its technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations. Its product candidates include The RedTail for Metastatic Solid Tumors, CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-101 (NeuroNova) for Newly Diagnosed High Grade Glioma.

About OFAL OFA Group Ordinary Shares

OFA Group provides interior design, fit-out, project management and application services in Hong Kong for commercial and residential buildings. Its interior design services include consultation, conceptualized designs, layout plans, detailed design drawings and advice on budgetary considerations, space utilization, materials, fittings, furniture, appliances and other items. Its fit-out services include the installation of protective materials, partition walls, windows, decorative fittings, furniture, fixtures, plumbing systems, switches, power outlets, telephone wiring, computer outlet covers and other electrical and wiring works. The Group is transitioning from a project-based model to a subscription-based model for AI tools, real estate development and senior care infrastructure.

Share on Social Networks: